In the first months of 2020, positive results in gene therapy of X-linked retinitis pigmentosa (XLRP) have been reported. XLRP is an inherited genetic disorder that causes progressive vision loss, mai...
Read moreResearchers from the Faculty of Medicine of the University of Barcelona and the CELLEX Biomedical Research Centre from IDIBAPS, in collaboration with scientists from the University of Sydney, Universi...
Read moreTelomerase is an enzyme that actively participates in the lengthening of telomeres by partly recovering the DNA that is destroyed in each cell division.
Read moreThe Research Institute of the Hospital de la Santa Creu i Sant Pau and the Autonomous University of Barcelona have created the Joint Research Unit in Genomic Medicine UAB – IR Sant Pau with the aim ...
Read moreThere is still no treatment for Stargardt’s disease, which mainly affects young people. However, the research is highly intensive and encouraging
Read moreA study, in which Dr. Jordi Surrallés, Professor of Genetics at the UAB, and his research group have participated, presents the first clinical demonstration of engraftment and expansion of gene-corre...
Read moreA draft NICE guidance recommends Voretigene Neparvovec (also called Luxturna) to treat people with vision loss caused by inherited retinal dystrophy from confirmed RPE65 gene mutations who have enough...
Read moreThe United States Food and Drug Administration (FDA) has just approved the designation of the QR-1123 therapy by the Dutch company ProQR as a new investigational drug. This drug aims to treat a form o...
Read moreReplacing the cells of a damaged tissue with healthy ones using stem cells is now a reality.
Read moreThe researchers have studied two viruses which live in salt lakes and have an extraordinary survival capacity, and are crucial in understanding some of the viruses of today.
Read moreThe European Union has awarded a grant of 15€ million for a research programme – CardioReGenix – to support new gene therapy approaches for the treatment of heart disease.
Read morePfizer and Vivet to collaborate on development of potential breakthrough therapy for Wilson disease
Read more